US drugs giant Pfizer has said demand for its COVID-19 vaccine could become 'durable' like flu jabs as it reported revenues of $3.5bn for the drug in the first quarter
US drugs giant Pfizer has said demand for its COVID-19 vaccine could become"durable" like flu jabs as it reported revenues of $3.5bn for the drug in the first quarter.
Pfizer also forecast that it would generate revenues of $26bn for the year as a whole, up from previous guidance of $15bn. The company said as of this week it had shipped 430 million doses of the vaccine and for the year as a whole has contracts to deliver 1.6 billon.The results come days after Anglo-Swedish rivalsales worth $275m of its coronavirus vaccine over the first quarter, representing about 68 million doses.
AstraZeneca, which unlike Pfizer is producing its vaccine at cost, revealed that it only represented 4% of sales during the period and that these actually dragged on profits.By contrast, Pfizer's sales of its vaccine - developed with Germany's BioNTech - represented about a quarter of its total revenues for the January-March period.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
COVID-19: Long COVID clinics may be needed beyond April next yearNHS England has spent £34m on opening 83 clinics but they could be necessary for longer than first thought.
Læs mere »
COVID-19: US regulators authorise use of Pfizer vaccine for ages 12 to 15The move offers protection for young people in the US before they head back to school in the autumn.
Læs mere »
Pfizer forecasts $26bn from annual sales of Covid-19 vaccineVaccine will generate 73% more than forecast based on contracts signed until mid-April
Læs mere »
COVID-19: Tinder owner eyes 'summer of love' surge as vaccinations increaseTinder's parent company Match Group has set its sights on a 'summer of love' surge for its global dating platforms as coronavirus vaccinations increase and economies reopen
Læs mere »